Service de Biologie Clinique, Hôpital Foch, 92150, Suresnes, France.
Service de Bactériologie et des Contrôles Microbiologiques, CHU de Nantes, 44000, Nantes, France.
Future Microbiol. 2023 Jan;18:117-126. doi: 10.2217/fmb-2021-0278. Epub 2023 Feb 1.
Meropenem-vaborbactam and delafloxacin activities were not assessed against spp. (), complex () and (). A total of 106 , 57 and 100 were tested with gradient diffusion test of meropenem-vaborbactam, delafloxacin and comparators. Meropenem-vaborbactam MIC were 4 μg/ml for , 1 μg/ml for , 2 μg/ml for and , and 32 μg/ml for . Delafloxacin MIC were 4 μg/ml for , 0.25 μg/ml for and , 2 μg/ml for , and 0.5 μg/m for . meropenem-vaborbactam MICs were fourfold lower than meropenem for 28.3% , 77.2% , 53.8% and 77.2% . Meropenem-vaborbactam and delafloxacin are active against and .
美罗培南-法硼巴坦和德拉沙星对 spp.()、 复合体()和 ()不进行评估。使用美罗培南-法硼巴坦、德拉沙星和对照品的梯度扩散试验,共测试了 106 株 、57 株 和 100 株 。美罗培南-法硼巴坦对 、 、 和 的 MIC 分别为 4μg/ml、1μg/ml、2μg/ml 和 32μg/ml。德拉沙星对 、 、 和 的 MIC 分别为 4μg/ml、0.25μg/ml、2μg/ml 和 0.5μg/ml。美罗培南-法硼巴坦对 28.3%、77.2%、53.8%和 77.2%的 MIC 比美罗培南低 4 倍。美罗培南-法硼巴坦和德拉沙星对 和 均具有活性。